Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Kite and ShoreLine Biosciences partner on allogeneic cell therapies for hematologic malignancies

June 18, 2021

Anji licenses rights to MCL1 inhibitor program from Broad Institute

June 18, 2021

4SC and NKI collaborate to study neoadjuvant domatinostat in urothelial carcinoma

June 18, 2021

Modus collaborates with Imperial College London on clinical study of sevuparin in malaria

June 18, 2021

Apexigen and NSGO-CTU to collaborate on phase II study of sotigalimab for ovarian cancer

June 17, 2021

Debiopharm and Ubix collaborate to develop antibody degraducer conjugates

June 17, 2021

Mydecine launches in silico drug discovery program with University of Alberta

June 17, 2021

MacroGenics and Zai Lab collaborate on bispecific molecules in immuno-oncology

June 17, 2021

Servier and Oncodesign's collaboration in Parkinson's selects preclinical candidate

June 16, 2021

Harbour BioMed and Dana-Farber Cancer Institute to codevelop novel biotherapies for cancer

June 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...